Cognitive Protection by Angiotensin Converting Enzyme Inhibitors in Heart Failure

Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure.

As a result of the increasing cost of health care and the limited resources available, it has become more difficult to allocate resources efficiently and effectively in the health care system. This environment has led to the development of pharmacoeconomic studies, which have been designed in response to the need for assessment of the economic benefits of a product prior to its acceptance in th...

Underutilization of angiotensin converting enzyme inhibitors among heart failure patients.

There are well-established guidelines regarding the use of Angiotensin converting enzyme inhibitors (ACEI) in the management of heart failure (HF). In-spite of that, many studies has documented underutilization of ACEI. Thus, this retrospective observational study aimed to evaluate the utilization of ACEI, to identify the pattern of ACEI use and the factors that might contribute to underutiliza...

Angiotensin converting enzyme inhibitors for hypertension and heart failure?

Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure.

AIMS Cognitive dysfunction is a prevalent condition among patients with heart failure, and is independently associated with disability and mortality. Angiotensin-converting enzyme (ACE)-inhibitors might increase cerebral blood flow in subjects with heart failure. Our aim was to assess whether starting treatment with ACE-inhibitors might improve cognition in patients with heart failure. METHOD...

Angiotensin Converting Enzyme in Sarcoidosis